![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Bladder Cancer |
Free Subscription
1 ACS Sens |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Urease-Driven Janus Nanomotors for Dynamic Enrichment and Multiplexed Detection
of Bladder Cancer MicroRNAs in Urine.
ACS Sens. 2025 Feb 5. doi: 10.1021/acssensors.4c02996.
PubMed
Abstract available
Clinical and pathological risk factors for tumour recurrence and upstaging in
second TURBT for patients with NMIBC: a systematic review and meta-analysis.
Aktuelle Urol. 2025;56:30-40.
PubMed
Abstract available
Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present,
and Future of Antibody-Drug Conjugate Development in Advanced Urothelial
Carcinoma.
Am Soc Clin Oncol Educ Book. 2025;45:e471924.
PubMed
Abstract available
Single-cell RNA sequencing analysis reveals the dynamic changes in the tumor
microenvironment during NMIBC recurrence.
Apoptosis. 2025;30.
PubMed
Abstract available
Best evidence for rehabilitation management of urinary incontinence in patients
with bladder cancer following orthotopic neobladder reconstruction.
Asia Pac J Oncol Nurs. 2024;12:100647.
PubMed
Abstract available
Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1
inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1
multicenter, open-label, single-arm clinical trial.
BMC Cancer. 2025;25:195.
PubMed
Abstract available
Clinical outcomes of nephroureterectomy with bladder cuff excision or radical
cystectomy for distal ureteral carcinoma invaded muscle of the ureteral orifice.
BMC Cancer. 2025;25:221.
PubMed
Abstract available
Blood lead levels and bladder cancer among US participants: NHANES 1999-2018.
BMC Public Health. 2025;25:416.
PubMed
Abstract available
Feasibility of enzalutamide on patients with recurrent non-muscle-invasive
bladder cancer with marker tumors: phase I study.
BMC Res Notes. 2025;18:47.
PubMed
Abstract available
2025 Canadian Urological Association Expert Report: Muscle-invasive bladder
cancer.
Can Urol Assoc J. 2025;19:E1-E16.
PubMed
Novel combination therapy for platinum-eligible patients with locally advanced or
metastatic urothelial carcinoma: a systematic review and network meta-analysis.
Cancer Immunol Immunother. 2025;74:76.
PubMed
Abstract available
Integrative analysis of patient-derived tumoroids and ex vivo organoid modeling
of ARID1A loss in bladder cancer reveals therapeutic molecular targets.
Cancer Lett. 2025 Jan 29:217506. doi: 10.1016/j.canlet.2025.217506.
PubMed
Abstract available
An Unusual Presentation of Bladder Carcinoma in a Visceral Hernia: A Case Report
and Literature Review.
Cancer Rep (Hoboken). 2025;8:e70128.
PubMed
Abstract available
Investigating the Potential to Offer Reproductive Organ Preserving Radical
Cystectomy to More Female Bladder Cancer Patients.
Clin Genitourin Cancer. 2025;23:102303.
PubMed
Abstract available
VI steps to achieve VI-RADS assessment.
Eur J Radiol. 2025;183:111868.
PubMed
Abstract available
Re: Characterizing Psychological Resources and Resilience in Patients with
Bladder Cancer: Associations with Frailty and Quality of Life.
Eur Urol. 2025 Feb 3:S0302-2838(25)00022-3. doi: 10.1016/j.eururo.2025.
PubMed
Re: Akihiro Matsukawa, Takafumi Yanagisawa, Marcin Miszczyk, et al. Trimodality
Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer: A
Systematic Review and Meta-analysis of Matched Cohort Studies. Eur Urol Focus. In
press. https://do
Eur Urol Focus. 2025 Feb 4:S2405-4569(25)00016-1. doi: 10.1016/j.euf.2024.
PubMed
Loss of YTHDC1 m(6)A reading function promotes invasiveness in urothelial
carcinoma of the bladder.
Exp Mol Med. 2025;57:118-130.
PubMed
Abstract available
Redefining bladder cancer treatment: innovations in overcoming drug resistance
and immune evasion.
Front Immunol. 2025;16:1537808.
PubMed
Abstract available
Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for
patients with bladder cancer.
Front Mol Biosci. 2025;11:1520223.
PubMed
Abstract available
Prognostic role of prognostic nutritional index in patients with bladder cancer:
a systematic review and meta-analysis.
Front Oncol. 2025;14:1486389.
PubMed
Abstract available
[The Case of Solitary Adrenal Metastasis of Urothelial Carcinoma].
Hinyokika Kiyo. 2025;71:5-8.
PubMed
Abstract available
Urachal Carcinomas: A Comprehensive Systematic Review and Meta-analysis.
Int Braz J Urol. 2025;51:e20240665.
PubMed
Abstract available
Multicenter Retrospective Registry Study on BCG Use in Non-Muscle Invasive
Bladder Cancer in Latin America: BLATAM (Bladder Cancer in Latin America) Group.
Int Braz J Urol. 2025;51:e20240615.
PubMed
Abstract available
Pelvic Lymph Node Dissection Before Versus After Radical Cystectomy: A Systematic
Review and Meta-Analysis.
Int Braz J Urol. 2025;51:e20240490.
PubMed
Abstract available
A novel mouse model of upper tract urothelial carcinoma highlights the impact of
dietary intervention on gut microbiota and carcinogenesis prevention despite
carcinogen exposure.
Int J Cancer. 2025;156:1439-1456.
PubMed
Abstract available
Unleashing the power of urine?based biomarkers in diagnosis, prognosis and
monitoring of bladder cancer (Review).
Int J Oncol. 2025;66:18.
PubMed
Abstract available
Image-Guided Brachytherapy for Pediatric Bladder and/or Prostate
Rhabdomyosarcoma: Toward an Increased Personalization of Treatment.
Int J Radiat Oncol Biol Phys. 2025;121:658-666.
PubMed
Abstract available
Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase
III Multicenter Randomized Controlled Trial.
Int J Radiat Oncol Biol Phys. 2025;121:728-736.
PubMed
Abstract available
Innovative logic "AND" gate gene circuits for bladder cancer treatment:
preclinical study.
Int J Surg. 2025 Feb 4. doi: 10.1097/JS9.0000000000002270.
PubMed
Abstract available
Stage III substaging and outcomes in patients with bladder cancer undergoing
radical cystectomy.
Int J Urol. 2025 Feb 5. doi: 10.1111/iju.70005.
PubMed
Abstract available
COTI-2 suppresses the malignancy of bladder cancer by inducing apoptosis via the
AMPK-mTOR signaling pathway.
Iran J Basic Med Sci. 2025;28:240-246.
PubMed
Abstract available
Multilevel plasticity and altered glycosylation drive aggressiveness in hypoxic
and glucose-deprived bladder cancer cells.
iScience. 2025;28:111758.
PubMed
Abstract available
S100A8 promotes the proliferation, migration and invasion in bladder cancer
cells.
J Cancer. 2025;16:1066-1077.
PubMed
Abstract available
Sex-specific differences in recurrence and progression following cytostatic
intravesical chemotherapy for non-muscle invasive urothelial bladder cancer
(NMIBC).
J Cancer Res Clin Oncol. 2025;151:59.
PubMed
Abstract available
Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging
Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder
Cancer?
J Clin Oncol. 2025 Feb 5:JCO2402482. doi: 10.1200/JCO-24-02482.
PubMed
Journal of Registry Management Continuing Education Quiz-FALL 2024: EVALUATION OF
MELANOMA AND BLADDER CANCERS IN NEW HAMPSHIRE TO IDENTIFY REGISTRAR TRAINING
NEEDS.
J Registry Manag. 2024;51:128.
PubMed
Abstract available
Evaluation of Melanoma and Bladder Cancers in New Hampshire to Identify Registrar
Training Needs.
J Registry Manag. 2024;51:121-123.
PubMed
Abstract available
Letter: Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO
Guideline: 2024 Amendment.
J Urol. 2025 Feb 7:101097JU0000000000004431. doi: 10.1097/JU.0000000000004431.
PubMed
Genome-wide association study and Mendelian randomization analyses reveal
insights into bladder cancer etiology.
JNCI Cancer Spectr. 2025 Feb 3:pkaf014. doi: 10.1093.
PubMed
Abstract available
Pseudoprogression Shown on (18)F-FDG PET/CT After Pembrolizumab Treatment in a
Case of Metastatic Bladder Cancer.
Mol Imaging Radionucl Ther. 2025;34:70-72.
PubMed
Abstract available
Perioperative Durvalumab in Bladder Cancer. Reply.
N Engl J Med. 2025;392:619.
PubMed
Perioperative Durvalumab in Bladder Cancer.
N Engl J Med. 2025;392:618-619.
PubMed
Proteomic profiling identifies muscle-invasive bladder cancers with distinct
biology and responses to platinum-based chemotherapy.
Nat Commun. 2025;16:1240.
PubMed
Abstract available
KRT18 as a Novel Biomarker of Urothelial Papilloma while Evaluating Low-Grade
Papillary Urothelial Neoplasms: Bi-Center Analysis.
Pathobiology. 2025;92:28-39.
PubMed
Abstract available
Comparison of fluorescence intensity of protoporphyrin IX as observed on the
screen of different cystoscopic systems.
Photodiagnosis Photodyn Ther. 2025;51:104425.
PubMed
Abstract available
Variations in the diagnostic performance of transurethral resection of bladder
tumor with photodynamic diagnosis according to surgical experience: A
retrospective, single-center study.
Photodiagnosis Photodyn Ther. 2025;51:104429.
PubMed
Abstract available
[Antibioprophylaxis failure with BCG therapy for bladder neoplasia].
Rev Mal Respir. 2025;42:75-80.
PubMed
Abstract available
Amyloids in bladder cancer hijack cancer-related proteins and are positive
correlated to tumor stage.
Sci Rep. 2025;15:4393.
PubMed
Abstract available
Cost-reduction strategy to culture patient derived bladder tumor organoids.
Sci Rep. 2025;15:4223.
PubMed
Abstract available
Tissue-Based Biomarkers Important for Prognostication and Management of
Genitourinary Tumors, Including Surrogate Markers of Genomic Alterations.
Surg Pathol Clin. 2025;18:175-189.
PubMed
Abstract available
Mesenchymal Neoplasms of the Bladder and Male Genital Tract, including the
Perineum and Scrotum.
Surg Pathol Clin. 2025;18:229-247.
PubMed
Abstract available
Molecular Classification of Urothelial Carcinoma.
Surg Pathol Clin. 2025;18:41-51.
PubMed
Abstract available
TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy
resistance.
Theranostics. 2025;15:1966-1986.
PubMed
Abstract available
Prognostic Significance of Albumin-Globulin Ratio in Urachal Carcinoma.
Urol Int. 2025;109:8-17.
PubMed
Abstract available
Comment on "Early Adjuvant Chemotherapy Improves Survival in Muscle Invasive
Bladder Cancer: A Systematic Review and Meta-analysis".
Urology. 2025 Jan 29:S0090-4295(25)00008-1. doi: 10.1016/j.urology.2025.
PubMed
Thank you for your interest in scientific medicine.